For laboratory research use only. Not for human or veterinary use.
PT-141

FOR RESEARCH USE ONLYNot for human or veterinary use of any kind
Full label. Lot number and expiry differ per batch and are printed on each vial.
PT-141
Also known as: Bremelanotide
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide studied for melanocortin receptor activity and central signaling involved in sexual motivation and arousal. It is supplied as a lyophilized powder for in vitro and analytical research.
- CAS
- 189691-06-3 (free peptide)
- M.W.
- Approximately 1,025.2 g/mol (free peptide)
- Formula
- C50H68N14O10
- Form
- Lyophilized powder
$49.00per vial
Price shown per vial. Quantity discounts below.
In stock
Buy more, pay less per vial
Add 1 more vial to save 3%: $47.53 per vial.
- Safe credit card paymentVisa, Mastercard and American Express
- 30-day money-back guarantee
- Super-fast 1-2 day shippingTo all 50 states and DC
- Free shipping on orders over $200Applied automatically at checkout

PT-141
10 mg · $49.00/vial
Lyophilized PT-141 storage
Keep sealed, dry and protected from light. Follow the label, SDS and lot-specific temperature and expiry instructions.
Reconstituted PT-141 storage
Validate solution stability for the experimental conditions.
PT-141 delivery and shipping
PT-141 ships from US stock to United States addresses only. Orders are packed and dispatched within 1-2 business days.
- Standard: $9.95, 1-2 business days after dispatch.
- Express: $24.95, next business day after dispatch.
Lyophilized PT-141 ships in a sealed glass vial with protective packaging. The dry powder is stable at room temperature for the length of domestic transit, so no cold pack is needed. Move it to the storage conditions above when it arrives.
Follow your parcel any time on the Track Order page.
PT-141 lab testing and COA
The certificate of analysis for PT-141 is being uploaded. Ask support for the current report before you order if you need it now.
Every vial label has a lot number. Check it on the Verify page to confirm the vial is genuine. All reports are on the Lab Reports page.
For laboratory research use only. All products are sold for laboratory research use only. They are not drugs, foods, cosmetics or dietary supplements, and are not for human or veterinary use.
PT-141 specifications
- Product
- PT-141
- Also known as
- Bremelanotide
- Compound class
- Melanocortin Peptides
- Product type
- Peptide
- Form
- Lyophilized powder
- Amounts available
- 10 mg ($49.00), 20 mg ($89.00)
- Chemical class
- Melanocortin receptor agonist
- Peptide length
- 7 amino acids; cyclic lactam structure
- Sequence
- Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Molecular formula
- C50H68N14O10
- Molecular weight
- Approximately 1,025.2 g/mol (free peptide)
- CAS number
- 189691-06-3 (free peptide)
- Research focus
- Melanocortin pharmacology; neuroendocrine signaling
- Storage as supplied
- Sealed, dry, dark; -20 °C for long-term storage
- Lab report
- COA on request
- Research areas
- Melanocortin Peptides
- Intended use
- Laboratory research only. Not for human or veterinary use.
Research overview
About PT-141
Scientifically reviewed by John Johnson · Updated November 2026PT-141 (bremelanotide) is a synthetic cyclic heptapeptide studied for melanocortin receptor activity and central signaling involved in sexual motivation and arousal. It is supplied as a lyophilized powder for in vitro and analytical research.[2][3]
PT-141 belongs to the family of synthetic analogues of alpha-melanocyte-stimulating hormone (alpha-MSH). Its research interest centers on melanocortin receptors, including MC3R and MC4R, and the neural pathways associated with their activation. Early experimental work connected PT-141 exposure with hypothalamic neuronal activity and behavioral responses in animal models.[1]
The literature spans receptor pharmacology, animal behavior and controlled human studies of specific investigational or pharmaceutical formulations. These sources describe the compound in different research settings; they do not establish the suitability of a research vial for clinical use.
What Is PT-141?
PT-141 is a seven-residue peptide with an acetylated N-terminus and a cyclic segment formed through an Asp-Lys lactam linkage. Its sequence contains norleucine and D-phenylalanine, so it differs from an unmodified fragment of endogenous alpha-MSH. The free peptide has a molecular weight of approximately 1,025.2 g/mol.[7]
PT-141 and bremelanotide refer to the same active peptide. Published clinical work concerns defined formulations and study populations. The supplied laboratory powder should be identified by its own lot documentation, including its salt form and analytical identity.
PT-141 Research Applications
Published studies place PT-141 within several related areas of melanocortin and neuroendocrine research:
- Melanocortin receptor pharmacology: Investigating agonist activity and the contribution of central melanocortin receptors, particularly MC3R and MC4R, to downstream responses. PT-141 is not a selective probe for just one receptor subtype.[1][6]
- Hypothalamic signaling: Examining neuronal activation associated with PT-141 exposure. Early rat experiments used c-Fos immunoreactivity to investigate activity in hypothalamic regions linked to sexual responses.[1]
- Behavioral neuroendocrinology: Studying sexual solicitation and motivation in female rat models. These experiments distinguish behavioral endpoints from general locomotor activity and provide a preclinical framework for central signaling research.[2]
- Pharmacokinetics and formulation: Comparing exposure and measured responses in early intranasal and subcutaneous studies. Route and formulation are part of the experimental context and cannot be treated as interchangeable.[3][4]
- Clinical endpoint research: Examining how desire and associated distress were measured in the RECONNECT trials. Across two trials, 1,267 women were randomized; results apply to the studied premenopausal HSDD population and pharmaceutical formulation.[5]
Evidence in context. Research on melanocortin signaling includes both laboratory and human evidence. The RECONNECT studies reported improvements in desire and related distress compared with placebo, alongside tolerability effects. Those results do not substantiate general performance claims or establish equivalence between a research powder and an approved medicine.[5][6]c
Catalog and source notes
| Catalog amounts / price | 10 mg: $49.00 | 20 mg: $89.00a |
| Shipping | US addresses only; listed dispatch time 1-2 business days. Standard shipping from $9.95.a |
| Lab reports / identity | COA on request. Use the vial lot number to request the matching analytical report and SDS. |
| Storage / handling | Keep sealed, dry and protected from light. Follow the label, SDS and lot-specific temperature and expiry instructions. Validate solution stability for the experimental conditions. |
Catalog source: local PT-141 product page. Prices, availability and shipping terms may change. Confirm the current listing before ordering.
a. Vial sizes and commercial details reflect the local catalog on 12 November 2026; confirm the current listing and matching lot COA. b. Formula and mass describe the free peptide; counterions, water and other lot constituents are excluded. Confirm the supplied chemical form.
c. Clinical studies cited here used specified formulations and enrolled populations. They do not validate this laboratory product.
Laboratory research only. The FAQs summarize compound identity and published evidence; they provide no administration guidance.
Sources and catalog checked 12 November 2026. Descriptive reference titles are labeled; article links identify the full publications.
Numbered citations throughout this description link directly to the sources below. Model notes identify the evidence each source provides.
PT-141 FAQ
Is PT-141 the same as bremelanotide?
Yes. PT-141 is the development code used for bremelanotide. The name identifies the active peptide; it does not identify the formulation, salt content, purity or intended use of a particular vial.[7]
Is PT-141 a peptide?
Yes. It is a synthetic cyclic heptapeptide, meaning that it contains seven amino-acid residues. Its structure includes a lactam ring, an N-terminal acetyl group and nonstandard amino-acid features.[7]
Which receptors does PT-141 act on?
It is a melanocortin receptor agonist with activity at multiple receptor subtypes. MC3R and MC4R are prominent in research on central signaling, but PT-141 should not be described as exclusively selective for either one.[6]
What is PT-141 studied for?
Does an approved bremelanotide medicine exist?
Yes. Vyleesi is an FDA-approved bremelanotide injection for a defined indication in premenopausal women with acquired, generalized HSDD. Its approval applies to that medicine. RUOPeptides laboratory powder is a separate research product.[6]
Do the published trials establish that research PT-141 is safe?
No. The approved medicine has warnings that include temporary blood-pressure increases, heart-rate reduction, nausea and focal hyperpigmentation. Clinical findings do not establish the safety of an unapproved research formulation or support self-experimentation.[6]
What does the amount on the vial mean?
A 10 mg or 20 mg label describes the catalog vial amount. It is not a per-use quantity or a research protocol. Confirm the supplied form, content basis and lot-specific analytical results in the current certificate of analysis.a
Scientific references
- [1]Molinoff PB, et al. (2003). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 994:96-102. doi: 10.1111/j.1749-6632.2003.tb03167.x. Early animal and human pharmacology.
- [2]Pfaus JG, et al. (2004). Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci USA. 101(27):10201-10204. doi: 10.1073/pnas.0400491101. Female rat behavioral model.
- [3]Diamond LE, et al. (2004). Intranasal PT-141: placebo-controlled safety, pharmacokinetic and pharmacodynamic evaluation [descriptive title]. Int J Impot Res. 16(1):51-59. doi: 10.1038/sj.ijir.3901139. Early human studies; intranasal formulation.
- [4]Rosen RC, et al. (2004). Subcutaneous PT-141: safety, pharmacokinetics and pharmacodynamic effects [descriptive title]. Int J Impot Res. 16(2):135-142. doi: 10.1038/sj.ijir.3901200. Early human pharmacology.
- [5]Kingsberg SA, et al. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 134(5):899-908. doi: 10.1097/AOG.0000000000003500. RECONNECT trials; defined HSDD population.
- [6]U.S. Food and Drug Administration (2026). Vyleesi prescribing information, revised October 2026. Official pharmaceutical label; not a research-vial specification. Open official source. Structure, approved indication and safety context.
- [7]Sigma-Aldrich. Bremelanotide acetate (SML2756): chemical identity and free-base molecular weight [descriptive title]. Manufacturer technical product record; accessed 12 November 2026. Open official source. Structural reference; not a COA for this supplier's lot.
Buying PT-141 for research in the USA
Price
From $49.00. 10 mg: $49.00, 20 mg: $89.00. Quantity discounts per size: 3% off 2 vials, 5% off 3-4 vials, 7% off 5+ vials.
Shipping
US addresses only. Orders are packed and dispatched within 1-2 business days. Standard from $9.95.
Proof it's genuine
Check the lot number on your vial on the Verify page.
Lab reports
COA and SDS documents are on the Lab Reports page.
Scientifically reviewed
Scientifically reviewed by John Johnson
Scientific reviewer · Last reviewed November 2026
John Johnson reviewed this PT-141 page for scientific accuracy: the compound's identity and specifications, the summaries of published studies, and the references they cite. The page describes laboratory and preclinical research only. It is not medical advice and gives no usage guidance.
Research information on this page summarizes published laboratory and preclinical studies. It is not usage guidance.



